LMCG Investments’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
CIP
BCM
LMCG Investments's RGEN Position: Q3 2024 in Review
LMCG Investments sold out of Repligen (RGEN) in Q3 2024, closing a stake of 3,507 shares — an estimated $442K sold.
LMCG Investments first reported a position in RGEN in Q1 2022 and held it in 10 quarters. The position peaked at $909K in Q4 2023. 444 funds tracked by Wall St. Rank hold RGEN as of Q3 2024.
- LMCG Investments reported no remaining Repligen position as of Q3 2024 after selling out during the quarter.
- LMCG Investments sold 3,507 Repligen shares in Q3 2024, an estimated $442K.
- LMCG Investments first reported a position in Repligen in Q1 2022 and held it in 10 quarters.
- LMCG Investments's Repligen position peaked at $909K in Q4 2023.
- 444 funds tracked by Wall St. Rank held Repligen as of Q3 2024.
Based on LMCG Investments's 13F filing for Q3 2024, filed 29 Oct 2024.